The transport barrier in intraperitoneal therapy

Area of Science:

• Physiology
• Cell Biology
• Clinical Medicine

Background:

• The peritoneal cavity is vital for drug delivery in chemotherapy and dialysis for patients with kidney failure.
• The peritoneal barrier is a complex biological structure, not a simple semipermeable membrane, involving cells, extracellular matrix, and microvessels.
• Understanding this barrier is key to managing fluid transport and therapeutic efficacy.

Purpose of the Study:

• To investigate the complex nature of the peritoneal barrier.
• To understand how fluid infusions and inflammation alter peritoneal transport.
• To explore new methods for preserving the peritoneal barrier's function.

Main Methods:

• Review of research on capillary barrier function and extracellular matrix.
• Analysis of peritoneal transport mechanisms.
• Discussion of cellular interactions in peritoneal inflammation.
• Mention of new animal models, including transgenic mice.

Main Results:

• The peritoneum is highly permeable to water, solutes, and proteins, lacking physical barrier properties.
• Mesothelial cells are key immune responders, producing cytokines and chemokines.
• Inflammation involving mesothelial, interstitial, and endothelial cells leads to angiogenesis, fibrosis, and altered barrier function.

Conclusions:

• The peritoneal barrier's function is dynamically altered by inflammation and fluid dynamics.
• New research and animal models are essential for developing strategies to maintain peritoneal barrier integrity.
• Preserving the peritoneal barrier is critical for effective regional chemotherapy and dialysis.